CH625795A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625795A5 CH625795A5 CH632677A CH632677A CH625795A5 CH 625795 A5 CH625795 A5 CH 625795A5 CH 632677 A CH632677 A CH 632677A CH 632677 A CH632677 A CH 632677A CH 625795 A5 CH625795 A5 CH 625795A5
- Authority
- CH
- Switzerland
- Prior art keywords
- trifluoromethyl
- general formula
- oxazoline
- radical
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
- C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7615601A FR2358890A1 (fr) | 1976-05-24 | 1976-05-24 | Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625795A5 true CH625795A5 (da) | 1981-10-15 |
Family
ID=9173528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH632677A CH625795A5 (da) | 1976-05-24 | 1977-05-23 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US4267345A (da) |
| JP (2) | JPS584715B2 (da) |
| AR (2) | AR219296A1 (da) |
| AT (1) | AT350062B (da) |
| AU (1) | AU517715B2 (da) |
| BE (1) | BE854908A (da) |
| CH (1) | CH625795A5 (da) |
| DE (1) | DE2723464C2 (da) |
| ES (1) | ES459086A1 (da) |
| FR (1) | FR2358890A1 (da) |
| GB (2) | GB1564268A (da) |
| GR (1) | GR61659B (da) |
| HU (1) | HU177039B (da) |
| IL (1) | IL52137A (da) |
| NL (1) | NL169182C (da) |
| NZ (1) | NZ184175A (da) |
| OA (1) | OA05668A (da) |
| PH (1) | PH13880A (da) |
| PT (1) | PT66584B (da) |
| SE (1) | SE7705986L (da) |
| SU (2) | SU725561A3 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2444673A1 (fr) * | 1978-12-20 | 1980-07-18 | Science Union & Cie | Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament |
| US4348247A (en) * | 1979-02-26 | 1982-09-07 | Rockwell International Corporation | Method of fabricating a reinforced tubular structure |
| ATE29494T1 (de) * | 1983-08-11 | 1987-09-15 | Synthelabo | Indol-derivate, verfahren zu deren herstellung und deren therapeutische anwendung. |
| JPH06312412A (ja) * | 1992-06-10 | 1994-11-08 | Nippon Hume Pipe Co Ltd | 模様付き複合コンクリート製品およびその成形方法 |
| AUPP020297A0 (en) * | 1997-11-05 | 1997-11-27 | University Of Melbourne, The | A novel receptor, and compounds which bind thereto |
| EP1385517A1 (en) * | 2001-04-16 | 2004-02-04 | University Of Virginia Patent Foundation | Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| EP2070923A1 (de) | 2007-12-11 | 2009-06-17 | Bayer CropScience AG | Insektizide Iminoheterocyclen |
| UY32940A (es) * | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
| AR085509A1 (es) | 2011-03-09 | 2013-10-09 | Bayer Cropscience Ag | Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas |
| IN2015DN01061A (da) | 2012-08-17 | 2015-06-26 | Bayer Cropscience Ag |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2889351A (en) * | 1956-05-25 | 1959-06-02 | Pfizer & Co C | Therapeutic agents |
| US3626067A (en) * | 1965-07-01 | 1971-12-07 | Du Pont | Substituted oxazolines, useful as pharmaceuticals |
| US3453284A (en) * | 1966-01-19 | 1969-07-01 | Du Pont | Certain 2-(substituted-anilino)-2-oxazolines |
| DE1670751A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen |
| US3622067A (en) * | 1969-06-13 | 1971-11-23 | Ok Partnership Ltd | Document coder |
| BE754832A (fr) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
| USRE27133E (en) | 1970-03-20 | 1971-06-01 | Cdj)zco | |
| GB1453703A (en) * | 1972-12-28 | 1976-10-27 | Science Union & Cie | Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them |
| US4102890A (en) * | 1972-12-28 | 1978-07-25 | Science-Union Et Cie, Societe Francaise De Recherche Medicale | 2-Amino oxazolines and process for making the same |
| FR2269341B1 (da) * | 1974-04-30 | 1978-07-28 | Castaigne Sa | |
| GB1475513A (en) * | 1974-06-20 | 1977-06-01 | Science Union & Cie | Benzylamine derivatives process for science union et cie benzylamine derivatives process for their production and pharmaceutical compositions containing them |
-
1976
- 1976-05-24 FR FR7615601A patent/FR2358890A1/fr active Granted
-
1977
- 1977-05-20 IL IL52137A patent/IL52137A/xx unknown
- 1977-05-23 GB GB21613/77A patent/GB1564268A/en not_active Expired
- 1977-05-23 AT AT368277A patent/AT350062B/de not_active IP Right Cessation
- 1977-05-23 SE SE7705986A patent/SE7705986L/xx unknown
- 1977-05-23 CH CH632677A patent/CH625795A5/fr not_active IP Right Cessation
- 1977-05-23 PT PT66584A patent/PT66584B/pt unknown
- 1977-05-23 BE BE177800A patent/BE854908A/xx unknown
- 1977-05-23 NZ NZ184175A patent/NZ184175A/xx unknown
- 1977-05-23 GR GR53532A patent/GR61659B/el unknown
- 1977-05-23 AU AU25376/77A patent/AU517715B2/en not_active Expired
- 1977-05-23 GB GB26511/78A patent/GB1564269A/en not_active Expired
- 1977-05-24 AR AR267755A patent/AR219296A1/es active
- 1977-05-24 JP JP52060367A patent/JPS584715B2/ja not_active Expired
- 1977-05-24 DE DE2723464A patent/DE2723464C2/de not_active Expired
- 1977-05-24 NL NLAANVRAGE7705727,A patent/NL169182C/xx not_active IP Right Cessation
- 1977-05-24 HU HU77SI1577A patent/HU177039B/hu unknown
- 1977-05-24 PH PH19810A patent/PH13880A/en unknown
- 1977-05-24 OA OA56177A patent/OA05668A/xx unknown
- 1977-05-24 ES ES459086A patent/ES459086A1/es not_active Expired
- 1977-05-24 SU SU772481553A patent/SU725561A3/ru active
-
1978
- 1978-10-18 AR AR274117A patent/AR222022A1/es active
- 1978-12-20 SU SU782699403A patent/SU791234A3/ru active
-
1979
- 1979-04-19 US US06/031,386 patent/US4267345A/en not_active Expired - Lifetime
-
1980
- 1980-02-22 JP JP2149380A patent/JPS55127390A/ja active Pending
- 1980-08-18 US US06/179,169 patent/US4315019A/en not_active Expired - Lifetime
- 1980-10-15 US US06/197,170 patent/US4315020A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2537677A (en) | 1978-11-30 |
| PT66584B (fr) | 1978-10-20 |
| DE2723464A1 (de) | 1977-12-08 |
| FR2358890A1 (fr) | 1978-02-17 |
| FR2358890B1 (da) | 1978-12-15 |
| JPS584715B2 (ja) | 1983-01-27 |
| NL169182B (nl) | 1982-01-18 |
| PT66584A (fr) | 1977-06-01 |
| AU517715B2 (en) | 1981-08-20 |
| PH13880A (en) | 1980-10-24 |
| DE2723464C2 (de) | 1983-08-11 |
| AT350062B (de) | 1979-05-10 |
| GR61659B (en) | 1978-12-05 |
| US4267345A (en) | 1981-05-12 |
| US4315019A (en) | 1982-02-09 |
| JPS55127390A (en) | 1980-10-02 |
| GB1564269A (en) | 1980-04-02 |
| AR222022A1 (es) | 1981-04-15 |
| NL169182C (nl) | 1982-06-16 |
| ATA368277A (de) | 1978-10-15 |
| BE854908A (fr) | 1977-11-23 |
| OA05668A (fr) | 1981-05-31 |
| SU791234A3 (ru) | 1980-12-23 |
| AR219296A1 (es) | 1980-08-15 |
| GB1564268A (en) | 1980-04-02 |
| SE7705986L (sv) | 1977-11-25 |
| ES459086A1 (es) | 1978-04-16 |
| US4315020A (en) | 1982-02-09 |
| IL52137A (en) | 1982-01-31 |
| NZ184175A (en) | 1979-07-11 |
| HU177039B (hu) | 1981-06-28 |
| SU725561A3 (ru) | 1980-03-30 |
| JPS5325565A (en) | 1978-03-09 |
| NL7705727A (nl) | 1977-11-28 |
| IL52137A0 (en) | 1977-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0576350B1 (fr) | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
| EP0463969B1 (fr) | Nouveau composés de l'acide 4-amino butyrique leur procédé de préparation et les préparations pharmaceutiques qui les contiennent | |
| EP0371876A1 (fr) | Composés isoxazoles et isoxazolines à activité anticonvulsivante, procédé de préparation et compositions thérapeutiques les contenant | |
| FR2670491A1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| FR2671083A1 (fr) | Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques. | |
| EP0110781A1 (fr) | (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant | |
| EP0213006B1 (fr) | Nouveaux dérivés du dihydro-2,3 benzofuranne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
| EP0092459A2 (fr) | Imidazo(1,2-a)pyridines, leur préparation et leur application en thérapeutique | |
| CH625795A5 (da) | ||
| BE897566A (fr) | Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces derives. | |
| CA2767893C (fr) | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
| EP0239436B1 (fr) | Nouveau dérivé tricyclique dénommé acide (chloro-3 méthyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazépine (1,2) yl-11 amino) -5 pentanoique, son procédé de préparation et les compositions pharmaceutiques qui le contiennent | |
| FR2662695A1 (fr) | Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant. | |
| EP0002978B1 (fr) | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique | |
| EP0376850B1 (fr) | Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant | |
| CH630382A5 (fr) | Pyrroloquinoxalines et leurs sels. | |
| FR2787451A1 (fr) | Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CA1081222A (fr) | Procede de preparation de nouvelles benzazepines et leurs sels | |
| CA2010529A1 (fr) | Derives de la 1-arylsulfonyl 2-piperidinone, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions les renfermant | |
| EP0105881B1 (fr) | Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant | |
| EP0926145A1 (fr) | Composés naphtaléniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| FR2539415A1 (fr) | Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique | |
| EP0158545B1 (fr) | Dérivés d'acide [alpha-(alkylaminométhyl)-benzylthio]-acétique, procédé de préparation et utilisation en thérapeutique | |
| EP0097546B1 (fr) | Benzhydrylsulfinyléthylamines, procédé de préparation et utilisation en thérapeutique | |
| EP0037777B1 (fr) | Procédé de préparation de cycloalcoyl propanol amines utiles comme médicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |